Lynparza breast cancer Clinical Experience Investigation

Trial Identifier: D0819C00005
Sponsor: AstraZeneca
NCTID:: NCT03590938
Start Date: August 2018
Primary Completion Date: March 2022
Study Completion Date: March 2022
Condition: Breast Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Japan Aomori, Japan, D0819C00005
Japan Ehime, Japan, D0819C00005
Japan Fukui, Japan, D0819C00005
Japan Gunma, Japan, D0819C00005
Japan Ibaraki, Japan, D0819C00005
Japan Kagawa, Japan, D0819C00005
Japan Kagoshima, Japan, D0819C00005
Japan Nagano, Japan, D0819C00005
Japan Nara, Japan, D0819C00005
Japan Okinawa, Japan, D0819C00005
Japan Shiga, Japan, D0819C00005
Japan Shimane, Japan, D0819C00005
Japan Toyama, Japan, D0819C00005
Japan Yamagata, Japan, D0819C00005